Ralph W. Stevenson - Concepedia

Author

Ralph W. Stevenson

Also Known As

1Ralph W. Stevenson, R Stevenson, R W Stevenson, R. Stevenson, R. W. STEVENSON, R. W. Stevenson, R.W. STEVENSON, R.W. Stevenson, RALPH W. STEVENSON, Ralph Stevenson

101

Publications

3.2K

Citations

H-Index

107

Concepts

All Affiliations

Pfizer (United States)Vanderbilt University National Institute for Medical Research

About

Ralph W. Stevenson is an author at Pfizer (United States) specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	49	2.4K
2	Health Sciences	23	30	1.8K
3	Natural Sciences	3	3	80
4	Education	1	1	16
5	Public Health	1	1	35

Ralph W. Stevenson

Publications

Citations

H-Index

Page 1

	Year	Citations
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose <i>in vivo</i> William H. Martin, Dennis J. Hoover, Sandra J. Armento, Proceedings of the National Academy of Sciences GlycobiologyMetabolic RemodelingExperimental PharmacologyCp-91149 AdministrationMetabolic Syndrome	1998	230
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). E. Michael Gibbs, Jeffrey L. Stock, Scott C. McCoid, Journal of Clinical Investigation Glucose HomeostasisInsulin SignalingDb/db MiceMetabolic SyndromeGlycemic Improvement	1995	226
Effects of Two Treatment Regimes with Synthetic Human Parathyroid Hormone Fragment on Bone Formation and the Tissue Balance of Trabecular Bone in Greyhounds R. D. Podbesek, C Edouard, Pierre J. Meunier, Endocrinology	1983	195
Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. Benton Adkins, Sharon R Myers, Gustaf N. Hendrick, Journal of Clinical Investigation GastroenterologyGlucose DeliveryGlucose BalanceConscious DogMetabolic Syndrome	1987	180
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Walter C. Soeller, Juliette Janson, S E Hart, Diabetes Obese AImmunologyIslet AmyloidInsulin SignalingHemizygous Transgenic Mice	1998	142
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. Judith L. Treadway, D. M. Hargrove, Nancy A. Nardone, Journal of Biological Chemistry Transgenic Mouse ModelsFree Fatty AcidsGlucose HomeostasisTransgenic MiceCaloric Restriction	1994	102
Actions of Novel Antidiabetic Agent Englitazone in Hyperglycemic Hyperinsulinemic <i>ob</i>/<i>ob</i> Mice Ralph W. Stevenson, Nancy J. Hutson, Michael N Krupp, Diabetes Metabolic SyndromeDiabetes ManagementBiochemistryMedicineCp 68722	1990	97
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial John F. Kokai‐Kun, Tracey Roberts, Olivia Coughlin, The Lancet Infectious Diseases Antimicrobial SusceptibilityAntibioticsPhase 2Bβ-Lactam-treated PatientsPlacebo-controlled Trial	2019	82
Similar Dose Responsiveness of Hepatic Glycogenolysis and Gluconeogenesis to Glucagon In Vivo Ralph W. Stevenson, Kurt Steiner, Mary A. Davis, Diabetes	1987	80
Role of Gluconeogenesis in Sustaining Glucose Production During Hypoglycemia Caused by Continuous Insulin Infusion in Conscious Dogs R. Tyler Frizzell, David W Biggers, D. Borden Lacy, Diabetes	1988	79

Page 1